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Abstract 
Neopicrorhiza scrophulariiflora (Pennell) D. Y. Hong is an endangered herbaceous medicinal plant found in 
subalpine and alpine zone of eastern Himalayas comprising Sikkim, Nepal, Bhutan and China. Rhizomes of 
Neopicrorhiza scrophulariiflora (hereinafter referred to as Neopicrorhiza) have medicinal properties and are 
highly traded in Nepal, India and China. Information on driving factors for demand of Neopicrorhiza from 
consumer perspective is unknown, knowledge of which is important because it can allow insights into future 
demand and sustainability of future trade. In this context, a survey was conducted among purchasers and 
consumers (patients) of end products (Ayurvedic medicines) containing Neopicrorhiza (n=513) in five different 
cities of Nepal from March to July 2017 using structured questionnaire to explore characteristics of consumers and 
consumption of end products of Neopicrorhiza. The utilization of Ayurvedic medicines containing Neopicrorhiza 
for treatment of health disorders of human is prevalent in Nepal. Men and women patients of diverse ages and with 
different socio-economic profiles were found to consume Ayurvedic medicines containing Neopicrorhiza to treat 
health disorders associated with different organ systems of body. The patients receiving Ayurvedic medicines 
containing Neopicrorhiza were children, adults and elders ranging from 1 to 98 years old (av. 37.6 years). 
Employed and unemployed, educated and illiterate consumers were found to consume Ayurvedic medicines 
containing Neopicrorhiza to treat their health disorders in Nepal. Patients receiving those medicines were from 
households having diverse annual cash income levels. The purchase and consumption of Ayurvedic medicine 
containing Neopicrorhiza was most often guided by a doctor’s prescription. Most of the respondents believed that 
the prices of those Ayurvedic medicines were fairer than other types of medicines. Similar studies are 
recommended in other countries like India and China where the Neopicrorhiza is exported from Nepal. 
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Introduction 
For most of the world's population, plants, based 
on many well-established systems of medicine, in either 
crude or extract form, represent the foundation of 
primary health care for the foreseeable future (1). 
Current evidence indicates that a huge number of 
people rely on medicinal plant products to maintain 
their health or treat health disorders, and that this 
number is unlikely to decrease in the foreseeable future 
(2). Thousands of species of plants are used in 
traditional and modern medicine throughout the world, 
and many more species are important to the growing 
market for plant-based cosmetics, essential oils, food, 
beverages and other products, representing by far the 
biggest use of the natural world in terms of number of 
species (3, 4, 5, 6, 7, 8). Herbal medicines have long 
been used for the prevention and treatment of a wide 
range of medical conditions, as well as for general 
health enhancement (9, 10, 11).  
Neopicrorhiza scrophulariiflora (Pennell) D. Y. 
Hong, Scrophulariaceae family, (hereinafter referred to 
as Neopicrorhiza) is an endangered medicinal herb 
found in the subalpine as well as alpine zone of the 
eastern Himalayas comprising Sikkim, Nepal, Bhutan 
and China (13,14). Neopicrorhiza, locally called Kutki, 
is assessed as being vulnerable in Nepal (15). Its dry 
rhizomes have been used for healing for centuries, 
which has become a commercial medicinal plant 
product nowadays. Nepal is estimated to supply 66 ± 
12% of Neopicrorhiza rhizomes in global supply chain 
(16). In Nepal, about 1,800 species, including 
Neopicrorhiza are currently in use for production of 
Ayurvedic, Unani, and Siddha medicines (17) and also 
for essential oils, cosmetics, aromatic foods and 
perfumes (18). Some studies have indicated a rising 
demand for Himalayan plant based medicinal and 
cosmetic products (19, 20) that will foster demand of 
raw materials, hence could lead to rise in harvest level 
of this species. The volume of medicinal plants traded 
from Darchula District of far-western Nepal in the fiscal 
year 2014-15 was 401 tons with a harvester value of 
USD 5.5 million, representing a 2.3 fold increase in 
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volume and 17.2 fold increase in value compared to 
1997-98 (55). Commercial gathering of selected 
medicinal plant species to meet increasing national and 
international market demand can result in over-
exploitation (12). Ghimire et al. (21) reported that the 
size class of rhizomes of Neopicrorhiza harvested for 
trade was signiﬁcantly smaller than those collected for 
health care, leading to premature harvesting. The trade 
may pose sustainability threats that are best understood 
by combining species-level biophysical, trade, and 
consumer studies (55). Despite the high levels of trade, 
information about the consumers and consumption of the 
end products of Neopicrorhiza is lacking in literature, 
hence leaving an information gap on what drives its 
demand. Obtaining product-level knowledge of demand 
drivers is a key research gap, closing it would allow us 
to more accurately predict trade changes and associated 
concerns, such as what species are likely to need (more) 
protection. There is not a single consumer survey study 
available for any of the species traded from Darchula 
District of far-western Nepal including Neopicrorhiza, 
and hence the factors determining the demand for any of 
these species remain unknown (55). Knowledge on 
consumption of medicinal plant products is essential for 
prediction of future demand of species and planning for 
sustainability of harvesting. The aim of this paper is to 
contribute for an understanding of the consumer 
characteristics and consumption of end products of 
commercially important medicinal plants by exploring 
the prevalence of consumption of the Ayurvedic 
medicines containing Neopicrorhiza in Nepal. Ayurvedic 
medicines in this study refer to finished herbal medicines 
that contain as active ingredients, parts of plants, or 
other plant materials, or combinations, used in the 
maintenance of health as well as in the prevention, 
diagnosis, improvement or treatment of physical and 
mental disorders. 
 
Materials and Methods 
The research was based on inductive social 
approach (56, 57) that begins with detailed observations 
of the world using social research methods, which 
moves towards more abstract generalizations and ideas, 
rather than applying hypothesis or theory. Three large 
cities from terai region (Butwal, Bharatpur, Birgunj) and 
two large cities from mid hill region (Gorkha 
headquarter and Kathmandu) were randomly selected for 
consumer study. Data were collected through consumer 
surveys in five cities of Nepal from March to July 2017. 
Face to face interviews were conducted using structured 
questionnaire with purchasers of the Neopicrorhiza-
containing Ayurvedic medicine/s in Ayurvedic 
pharmacies on the spot. Prior consent was taken with 
respondents before the interview. Nineteen enumerators 
working in the Ayurvedic pharmacies having good 
knowledge on the ingredients of the medicines were 
mobilized for surveys. These enumerators were able to 
identify the Ayurvedic medicine in which Neopicrorhiza 
was present as an ingredient, so they conducted 
interviews to those who purchased only those medicines. 
The list of Ayurvedic medicines containing 
Neopicrorhiza used in this research is available in Kafle 
et.al., (53). One hundred one (101) purchasers of 
Neopicrorhiza-containing Ayurvedic medicines were 
surveyed in Bharatpur (19.7%), 12 in Birgunj (2.3%), 
167 in Butwal (32.6%), 52 in Gorkha Headquarter 
(10.1%), and 181 in Kathmandu (35.3%). In total, 513 
purchasers were surveyed: a) 280 in terai and b) 233 in 
mid hill.  
The main tool for the data collection was a 
structured questionnaire, finalized after pre testing and 
was composed of three main sections. Section one of 
the questionnaire included demographic characteristics 
of the respondents mainly sex, age, education, 
household annual cash income and belief on price and 
side effects of the Ayurvedic medicines. Section two 
included demographic characteristics of the patients or 
consumers mainly sex, age, education and occupation. 
Section three included characteristics related to 
consumption of Neopicrorhiza-containing Ayurvedic 
medicines mainly name of the medicine, prescription 
status, combination with allopathic medicine, belief on 
the price and side effects of the medicine, annual (past 
year's) expense on the medicine and quantity of the 
medicine purchased for consumption. The questionnaire 
is available in Smith-Hall et al. (51). 
The research did not require approval of ethics 
from government of Nepal since it was a pure academic 
research mainly based on non-invasive and non-
destructive methods (i.e. interviews) with full 
anonymity of the respondents. In this study, the 
respondents refer to purchasers of the Ayurvedic 
medicine/s containing Neopicrorhiza and the consumers 
refer to patients who will consume the purchased 
Ayurvedic medicine/s containing Neopicrorhiza, 
starting consumption within 24 hours from the time of 
purchase. The words ‘consumer’ and ‘patient’ are used 
interchangeably in this paper. The words ‘respondent’ 
and ‘purchaser’ are used interchangeably in this paper.  
Data were analyzed using IBM Statistics SPSS 
20. Descriptive statistics including frequency, 
percentage, mean, standard deviation as well as 
inferential statistics including binomial test and Chi 
square test were used. As we did not know about the 
population containing respondents, non-parametric tests 
were chosen for inferential analysis. One sample Chi 
square and binomial test were used to examine the 
statistical differences in different categories of the 
variables. Association of demographic variables with 
consumer’s preference for prescribed versus non 
prescribed Neopicrorhiza products was examined using 
Chi square test. Association of health disorder type and 
age of the consumers was examined with Chi square 
test. Nepali Rupees (NRs) was converted into United 
States Dollar (USD) using the rate specified on 29 
February 2018: 1 USD = 103.50 NRs according to 
Central Bank of Nepal (22). 
 
Results 
Characteristics of purchasers of Ayurvedic 
medicines containing Neopicrorhiza (respondents) 
Characteristics of the respondents are 
summarized in table 1. The respondents comprised of 
60.4% male and 39.6% female. Out of 513 respondents 
who participated in this study, the highest age frequency 
(n=320; 62.4%) was between 26 to 50 years of age, and 
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the lowest age frequency (n=4; 0.8%) was above 75 
years of age. The mean age of the respondent was 
36.5±12.9 years. The highest education frequency 
(n=145; 28.3%) was intermediate and equivalent level 
and the lowest education frequency (n=25; 4.9%) was 
postgraduate and above. The respondents had different 
annual household cash income level. Most of the 
respondents (n=168; 32.7%) had annual household cash 
income of USD 966.19 to 1932.37 while the lowest 
number of respondents (n=48, 9.4%) had that of USD 
2898.56 to 3864.73. 
 
Table 1 Characteristics of purchasers of Ayurvedic 
medicines containing Neopicrorhiza (respondents) 
 
SLC = School Leaving Certificate (to be received after 
successful completion of 10 years of school level 
education in school in Nepal) 
Exchange rate: 1 USD = 103.50 Nepali Rupees (NRs) as 
of 28 February 2018 according to Central Bank of Nepal 
(22) 
 
Consumption of Neopicrorhiza-containing 
Ayurvedic medicines 
In total, 513 respondents were interviewed using 
structured questionnaire who purchased at least 
Ayurvedic medicine containing Neopicrorhiza. 361 
respondents (70.4%) purchased only one Neopicrorhiza-
containing Ayurvedic medicine,75 respondents (14.6%) 
Variable Frequency Percentage 
Sex   
 Males 310 60.4 
 Females 203 39.6 
Age (years)   
 Up to 25 117 22.8 
 26-50 320 62.4 
 51-75 72 14.0 
 Above 75 4 0.8 
Education   
 Illiterate 32 6.2 
 Primary 58 11.3 
 Lower secondary 29 5.7 
 Secondary 47 9.2 
 SLC and equivalent 80 15.6 
 Intermediate and 
equivalent 
145 28.3 
 Graduate and 
equivalent 
97 18.9 
 Postgraduate 
equivalent and above 
25 4.9 
Household income (cash) USD/year 
 0 to 966.18 88 17.2 
 966.19 to 1932.37 168 32.7 
 1932.38 to 2898.55 84 16.4 
 2898.56 to 3864.73 48 9.4 
 3864.74 to 4830.92 58 11.3 
 Above 4830.92 67 13.1 
respondents purchased two Neopicrorhiza-containing 
Ayurvedic medicines,  53 respondents (10.3%) 
purchased  three Neopicrorhiza-containing Ayurvedic 
medicines and 24 respondents (4.7%) purchased four 
Neopicrorhiza-containing Ayurvedic medicines to be 
consumed by the patients. 
A total of 30 Ayurvedic medicines that contain 
Neopicrorhiza as an ingredient were found purchased 
for consumption by the consumers. Those medicines 
and the number of consumers consuming particular 
medicine is presented in table 2. Rohitkyadi Churna, 
Pilarin, Mahayograj Guggul, Kasarin, Nimbadi Churna, 
Arogyavardhini Vati, MVLiv, Piles Cure Oil, Hepatop, 
Asthamarin and Livherb are the top Ayurvedic 
medicines containing Neopicrorhiza in terms of 
intention for consumption, with Rohitkyadi Churna in 
first number.  
 
Table 2 Consumption rate of the Ayurvedic 
medicines containing Neopicrorhiza adopted by 
consumers  
 
Neopicrorhiza 
products 
Number 
of 
responses 
% 
respons
es 
%
cases 
Rank 
Rohitkyadi 
Churna 
131 17.7 25.5 1 
Pilarin 109 14.7 21.2 2 
Mahayograj 
Guggul 
83 11.2 16.2 3 
Kasarin 59 8.0 11.5 4 
Nimbadi 48 6.5 9.4 5 
Arogyavardhin
i Vati 
38 5.1 7.4 6 
MVLiv 30 4.0 5.8 7 
Piles Cure Oil 29 3.9 5.7 8 
Hepatop 25 3.4 4.9 9 
Asthamarin 23 3.1 4.5 10 
Livherb 23 3.1 4.5 11 
Mana 20 2.7 3.9 12 
Kumaryasava 17 2.3 3.3 13 
Glowderm 14 1.9 2.7 14 
Vata Raktahar 
Churna 
14 1.9 2.7 15 
Livosave 13 1.8 2.5 16 
Sarivadyasava 12 1.6 2.3 17 
Jivan Shakti 
Prash 
10 1.3 1.9 18 
Pittaghna 9 1.2 1.8 19 
Livotop 7 0.9 1.4 20 
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The consumers were categorized into two groups 
according to their preference to the consumption of 
prescribed or over the counter (OTC) products/
medicines: consumers who prefer prescribed 
Neopicrorhiza-containing Ayurvedic medicines were 
considered as “guided consumers”, consumers who 
prefer over the counter (OTC) Neopicrorhiza-containing 
Ayurvedic medicines were considered as “free 
consumers”. 382 (74.5%) of the consumers had 
preference to prescribed Neopicrorhiza products, i.e. 
they were guided consumers. Consumer in this study 
refers to patient who will consume the purchased 
Ayurvedic medicine/s containing Neopicrorhiza, 
starting consumption within 24 hours from the time of 
purchase. 
 
Characteristics of consumers (patients) 
Out of the 513 patients, 286 (55.8%) were male. 
The mean age of patients was 37.6±16.6 years. The 
patients ranged from 1 to 98 years of age. 267 (52.0%) 
patients were between 26 to 50 years of age, while 10 
(2%) were above 75 years of age. The highest education 
frequency (n=118; 23.0%) was intermediate level and 
the lowest education frequency (n=21; 4.1%) was 
postgraduate and above. The household of the patients 
had different annual cash income level. Most of the 
patients (n=168; 32.7%) had annual household cash 
income of USD 966.19 to 1932.37 while the lowest 
number of patients (n=48, 9.4%) had that of USD 
2898.56 to 3864.73 (Table 3).  
Out of the total patients, 382 (74.0%) were about 
to consume Neopicrorhiza-containing Ayurvedic 
medicines prescribed by an Ayurvedic doctors or health 
workers. Only 30 (6%) patients were about to 
Neopicrorhiza-containing Ayurvedic medicines in 
combination with allopathic medicine. All groups of 
patients including businessmen, farmers, job holders, 
students, housewives and unemployed persons preferred 
Neopicrorhiza-containing Ayurvedic medicines for their 
healthcare. Businessmen represented the highest 
consumers (n=126; 24.5%) while unemployed persons 
represented the lowest occupation frequency (n=9; 
1.7%) (Table 3). 
Neopicrorhiza 
products 
Number 
of 
responses 
% 
respo
nses 
%
cases 
Rank 
Tonoliv 6 0.8 1.2 21 
Lacchadi Oil 5 0.7 1.0 22 
Jameda Churna 4 0.5 0.8 23 
Maha 
Sudarshan 
Churna 
4 0.5 0.8 24 
Livorin 3 0.4 0.6 25 
Hepadex 2 0.3 0.4 26 
Hepagard DS 1 0.1 0.2 27 
Livergen 1 0.1 0.2 28 
Megaferol 1 0.1 0.2 29 
Yakrit Rasayan 
Churna 
1 0.1 0.2 30 
Grand Total 742 100 144.6   
52 respondents believed that the price of 
Ayurvedic medicines containing Neopicrorhiza was low 
(6.8%), 267 respondents believed that it was high 
(34.9%), and 447 believed that it was fair (58.4%). 
 
Table 3 Characteristics of patients (consumers) of 
Neopicrorhiza-containing Ayurvedic medicines 
 
Variable Frequency
(%) 
Chi Square/ 
Binomial 
(Goodness 
of fit) 
p-value 
Sex  
Males 286 (55.8) 
286  0.010*  
Females 227(44.2) 
Age (years)  
Upto 25 136 (26.5) -  -  
26-50 267 (52.0) 
51-75 100 (19.5) 
Above 75 10 (2.0) 
Education  
Illiterate 50 (9.7) 
115.195   0.000*  
Primary 87 (16.9) 
Lower secondary 30 (5.9) 
Secondary 48  (9.4) 
SLC and equivalent 81 (15.8) 
Intermediate and 
equivalent 
118 (23.0) 
Graduate and 
equivalent 
78 (15.2) 
Postgraduate 
equivalent and 
above 
21 (4.1) 
Household income (cash) NRs/ year  
0 to 966.18 88 (17.2) 
106.287   0.000* 
966.19 to 1932.37 168 (32.7) 
1932.38 to 2898.55 84 (16.4) 
2898.56 to 3864.73 48 (9.4) 
3864.74 to 4830.92 58 (11.3) 
Above 4830.92 67 (13.1) 
Was the medicine prescribed by a doctor? 
Yes 382 (74.0) 
382.00  0.000*  
No 131 (26.0) 
Belief regarding price of the Neopicrorhiza product 
Cheap 39(7.6) 
188.22  0.000*  Fair 293(57.11) 
Expensive 181(35.28)  
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SLC = School Leaving Certificate (to be received after 
successful completion of 10 years of school level 
education in school in Nepal) 
Exchange rate: 1 USD = 103.50 Nepali Rupees 
(NRs) as of 28 February 2018 according to Central Bank 
of Nepal (22) 
 
Health disorders of patients for which 
Neopicrorhiza-containing Ayurvedic medicine was 
purchased 
The Ayurvedic medicines containing 
Neopicrorhiza were used to treat disorders related to 
Circulatory system, Digestive system, Hepatobiliary 
system, Immune system, Integumentary system, 
Muscular system, Nervous system, Reproductive 
system, Respiratory system, Skeleton system and 
Urinary system (Table 4). Highest number of patients 
(174, 33.29%) had digestive system disorders to treat 
using Ayurvedic medicines, followed by disorders 
associated with hepatobiliary system, respiratory system, 
integumentary system, skeleton system, circulatory 
system, muscular system, immune system, nervous 
system, urinary system and reproductive system in 
chronological order.  
 
Table 4 Health disorder types for which 
Neopicrorhiza-containing Ayurvedic medicine was 
used 
 
Variable Frequency
(%) 
Chi Square/ 
Binomial 
(Goodness 
of fit) 
p-value 
Is this Ayurvedic medicine used in combination with 
allopathic medicine to treat the health disorder? 
Yes 30 (6.0) 
483.00  0.000*  
No 483 (94.0) 
Occupation 
Business 126 (24.5) 
106.333  0.000*  
Farmer 82 (15.9) 
Housewife 72 (14.04) 
Job holder 
(salaried) 
112 (21.8) 
Student 112 (21.8) 
Unemployed 9 (1.7) 
Disorder type Frequency Percentage 
Circulatory system 
Anemia 
Blood impurity 
Broken blood vessel 
Diabetes 
Heartburn 
High blood pressure 
Hyperuricemia (High Uric 
Acid) 
32 
4 
5 
1 
5 
2 
8 
7 
6.24 
Digestive system 
Abdominal pain 
Abdominal swelling 
174 
11 
2 
33.92 
 
Disorder type Frequency Percentage 
Anorexia (loss of appetite) 
Anorexia and constipation 
Anorexia and gastritis 
Constipation 
Dyspepsia (indigestion) 
Dyspepsia and abdominal 
pain 
Dyspepsia and anorexia 
Dysphonia (hoarse voice) 
Fistula 
Gastritis 
Hematochezia (blood from 
stool) 
Hemorrhoid (piles) 
Mouth sores 
16 
1 
1 
9 
18 
 
1 
1 
3 
1 
28 
3 
 
78 
1 
 
Hepatobiliary system 
Gallstones (Cholelithiasis) 
Hepatitis 
Jaundice 
Liver disorder 
Fatty liver 
85 
1 
1 
36 
43 
4 
16.57 
Immune system 
Asthenia (weakness) 
Health maintenance 
Underweight 
17 
15 
1 
1 
3.31 
Integumentary system 
Acne vulgaris (pimple) 
Age spots 
Pruritus (itchy skin) 
Psoriasis (reddish, scaly 
rash on skin) 
Skin allergy 
Tinea/Ringworm infection/
Eczema 
52 
4 
2 
13 
 
1 
31 
 
1 
10.14 
Muscular system 
Burning legs 
Edema (muscle swelling) 
Fever 
Myalgia (muscle pain) 
Myalgia and Edema 
numbness in body 
numbness in body and My-
algia 
Numbness in hands and 
legs 
Numbness in knee 
26 
1 
3 
4 
12 
1 
1 
1 
 
2 
 
1 
5.07 
Nervous system 
Eating disorder 
Fatigue 
Obesity 
9 
1 
7 
1 
1.75 
Reproductive system 
Leucorrhoea (whitish vagi-
nal discharge) 
Metrorrhagia (irregular 
menstruation) 
Uterine problem 
5 
2 
 
2 
 
1 
0.97 
Respiratory system 
Asthma 
Chronic bronchitis 
Chronic cough 
Cough 
Cough and common cold 
Cough and fever 
Itchy throat 
Pneumonia 
Sinusitis 
67 
14 
2 
5 
23 
9 
7 
1 
2 
4 
13.06 
Published online in http://ijam. co. in 
128 
International Journal of Ayurvedic Medicine, 2018, 9(2), 123-132 
ISSN: 0976-5921 
The names of disorders were adopted from (23). 
 
Association of demographic variables with patient’s 
preference for prescribed versus non prescribed 
Neopicrorhiza-containing Ayurvedic medicines  
Association was found between patient types in 
terms of preference to consumption of prescribed or non
-prescribed medicines and location (cities) (p=0.001), 
consumption of particular Ayurvedic medicine 
(p=0.000), occupation of the patient (p=0.023) (Table 
5). No association was found between patient types in 
terms of consumption of prescribed or non-prescribed 
medicines and annual household cash income, quantity 
of Ayurvedic medicine purchased for consumption, 
amount of total expense in Ayurvedic medicine in past 
12 months, consumption of the Ayurvedic medicine 
with other types of medicine, belief of the patient on the 
price of the Ayurvedic medicine, sex of the patient, age 
of the patient and education level of the patient. 
 
Table 5 Association of demographic variables with 
patient’s preference for prescribed versus non 
prescribed Neopicrorhiza-containing Ayurvedic 
medicines 
 
 
Discussion 
This research has provided important insights 
into the consumption of end products containing 
Neopicrorhiza in Nepal, based on research conducted in 
five large cities of Nepal. Research on consumer 
characteristics and consumption of end products of 
Neopicrorhiza is lacking in the scientific literature. In 
this context, it is believed that this study reveals the 
characteristics of Nepalese consumers consuming end 
products containing Neopicrorhiza and may serve as an 
entry point for future studies concerning the 
consumption of medicinal plant products. The study 
Disorder type Frequency Percentage 
Skeleton system 
Rheumatoid Arthritis 
40 7.80 
Urinary system 
Dysuria (painful urination) 
Nephrolithiasis (kidney 
stones) 
6 
4 
 
2 
1.17 
Variables Chi square ρ-value 
Age 63.077 0.855 
Sex 0.039 0.844 
Education level 13.330 0.064 
Occupation 12.9888 0.023* 
Annual household cash 
income 
8.542 0.129 
Combination of Ayurvedic 
medicine with allopathic 
medicine 
0.021 0.884 
Belief of the patient on the 
price of the Ayurvedic 
medicine 
2.711 0.258 
Expense on the product during 
last 12 months 
98.514 0.078 
* p < 0.05 is considered as 
statistically significant. 
-  
approach might be useful for replicating similar studies 
in future. 
Children are encouraged to use herbs for their 
nutritional values to facilitate normal or healthy growth 
and development; young persons for their euphoric 
effects, supply essential ingredients to help them cope 
with daily stress and to prevent or slow the onset of 
aging; older persons for their anti-aging or rejuvenating 
effects and women for slimming and beauty enhancing 
effects (54). Our study showed that children, adults and 
elders ranging from 1 to 98 years old (av. 37.6 years) 
consumed Ayurvedic medicines containing 
Neopicrorhiza in Nepal. The number of consumers was 
found increasing up to 40 years of age but after that 
decreasing. However, analyzing consumers with 10 
years of age interval, the number of respondents of two 
age categories: 21-30 years and 31-40 years were found 
with more consumers: 119 and 133 respectively than 
other age groups. Our findings are consistent with some 
previous research findings. Du et al. (24) found that use 
of herbal medicine declines along with increasing age in 
Germany. Arcury et al. (25) and Ness et al. (26) found 
that older American individuals did not favor the use of 
herbal medicine. Thorsen and Pouliot (28) found age as 
significant determinant of use of traditional medicine in 
mid hill region of Nepal. The traditional medicine was 
primarily relied on by middle-aged individuals from 
relatively uneducated households who were living in 
villages with limited allopathic medicine service 
provision (29). It is argued that herbal remedies are 
likely to be used by the relatively young users (30). The 
respondent age correlated inversely with the use of 
herbal supplements among older Americans (26). 
Arcury et al. (25) found that herbal remedy use declined 
with age. But in the case of patients with diabetes, 
previous studies showed contrasting results. Egede et al. 
(27) found that older age is associated with higher 
likelihood of using Complementary and Alternative 
Medicine among people living with diabetes. Older 
participants were likely to use complementary and 
alternative medicine in people with type 2 diabetes in 
Taiwan (31). It might be due to need for long term 
adherence of older persons to specific medicines for 
treating specific disease. 
We found that both educated and illiterate people 
consumed Ayurvedic medicines containing 
Neopicrorhiza in Nepal. The majority of the consumers 
were educated; only 9.7% consumers were illiterate. 
However, the education levels of the consumers were 
significantly different (p-value=0.000). Our findings on 
consumption of Ayurvedic medicines by both literate 
and illiterate persons, and higher number of literate 
consumers were consistent with findings of a number of 
previous researches. Educational level was key 
determinant of herbal medicinal product use in 
Germany (24). Egede et al. (27) and Bell et al. (32) 
found that having a higher educational background is 
associated with a higher likelihood of using 
Complementary and Alternative Medicine among 
people living with diabetes. Education was identified as 
significant determinant of use of traditional medicine in 
mid hill region of Nepal (28). Nur (30) argued that 
herbal remedies are likely to be used by those with 
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higher education. Ness et al. (26) found that advanced 
education correlated with fewer chiropractic visits and 
more dietary and herbal supplement and personal 
practices use. Education was one of the significant 
predictor of herb use among older American adults (25). 
Education did not demonstrate any relationship to 
complementary and alternative medicine use in people 
with type 2 diabetes in Taiwan (31). Education often 
promotes beliefs and ideas that clash with local 
traditions in developing countries and are associated 
with a reduction in the use of indigenous herbal/animal 
medicine (33).  
It is found that people from households having 
diverse annual cash income consumed Ayurvedic 
medicines containing Neopicrorhiza in Nepal. The 
income levels of the consumers were significantly 
different (p-value=0.000). About half of the consumers 
had annual household cash income level USD 966.19 to 
2898.55, while only 17.2% consumers had this income 
level below USD 966.19. Nepal's average monthly 
household income is USD 277.83 from 2006 to 2015 
(34). We found that around two third of the consumers 
had annual household cash income level below Nepal's 
average monthly household income. The average annual 
expenditure on Neopicrorhiza-containing Ayurvedic 
medicine per consumer is only USD 14.8. In Ghana, 
traditional medicine use was predicted by having low-
income levels (35). Sato (36) found that rising income 
is associated with decreased use of traditional care. 
Khan et al. (37) and UN Millennium Project (38) 
reported that the rich are more likely to utilize modern 
health care, owing to their greater means to access. 
High income was an important determinant of use of 
traditional medicine, challenging the common 
assumption that poor and marginalized people are most 
reliant on traditional medicine due to its availability 
(28). In Taiwan, income did not demonstrate any 
relationship to complementary and alternative medicine 
use in people with type 2 diabetes (31). In our study, 
preference to prescribed or non-prescribed 
Neopicrorhiza-containing Ayurvedic medicine was not 
found significantly associated with annual household 
cash income level of the consumer (p=0.778).  
Our results showed that both employed and 
unemployed people consumed Ayurvedic medicines 
containing Neopicrorhiza in Nepal. The occupation of 
the consumers is diverse: business, farmer, housewife, 
salaried job and student. The share of unemployed 
consumers was low (1.7%). Nature of occupation (being 
a trader) was found predictive of traditional medicine 
use in Ghana (35). In Taiwan, employment status did 
not demonstrate any relationship to complementary and 
alternative medicine use in people with type 2 diabetes 
(31). In our study, preference to prescribed or non-
prescribed Neopicrorhiza-containing Ayurvedic 
medicine was found significantly associated with 
occupation of the consumer (p=0.023), with highest 
number of consumers as being businessmen (126; 91 
taking prescribed medicines and 35 taking non 
prescribed ones) and lowest as being unemployed (9).  
Ayurvedic medicinal plant products are most 
convenient and have greater acceptance amongst the 
users due to their easy availability, easy 
biodegradability, easy to handling, economic cost, 
mankind and environment friendly nature both and 
minimum side effect (52). In this study, most 
respondents believed that the prices of Ayurvedic 
medicines containing Neopicrorhiza are fairer than other 
types of medicines. One of the factors that hindered 
herbal medicine use among Ghanaian adults included 
high cost of herbal products at credible herbal clinics 
(41).  
We found that the Ayurvedic medicines 
containing Neopicrorhiza were used by patients having 
a number of health disorders associated with Circulatory 
system, Digestive system, Hepatobiliary system, 
Immune system, Integumentary system, Muscular 
system, Nervous system, Reproductive system, 
Respiratory system, Skeleton system and Urinary 
system in Nepal. However, there is variation in the 
number of patients with specific disorders receiving 
these medicines. We found highest share of patients 
having abdomen related disorders (259, 50.49%) 
receiving Neopicrorhiza-containing medicines and the 
lowest share of patients having reproductive system 
disorders (5, 0.97%) receiving these medicines. It 
should be noted that the patients might receive other 
Ayurvedic medicines together with Neopicrorhiza-
containing Ayurvedic medicines for the treatment of 
their heath disorders, so we could not generalize about 
priority of disease types which Neopicrorhiza-
containing Ayurvedic medicine is effective for. But our 
study confirmed the diseases to which Neopicrorhiza-
containing Ayurvedic medicines were used for healing. 
Previous studies had explored the use of the raw 
(unprocessed) Neopicrorhiza rhizomes to treat various 
ailments such as liver disorders, fever, asthma, jaundice 
and have pharmaceutical value for hepatoprotective, 
immunomodulator and antiasthamatic activities (42, 43, 
44) in Indian, Bhutanese, Tibetan and Chinese 
traditional medicines. Medicinal values of 
Neopicrorhiza are due to the presence of irridoid 
glycosides such as picroside I and II, and kutkoside (45, 
46, 47, 48, 49). An in vitro study suggested antihepatitis 
B-like activity of Neopicrorhiza through reduction in the 
levels of surface antigens (50). 
 
Conclusion 
This research presents a first exploration of 
consumption of the Ayurvedic medicines containing 
Neopicrorhiza and consumer characteristics in Nepal. 
The consumption of Ayurvedic medicines containing 
Neopicrorhiza is prevalent in Nepal. These medicines 
are consumed by children, adults and elders of 
households having diverse annual household cash 
income levels. Both illiterate and educated persons 
prefer these medicines. Majority of the patients prefer to 
consume medicines after receiving prescription from 
Ayurvedic doctors and professionals. Major proportions 
of the patients believe that the price of the 
Neopicrorhiza-containing medicines is fairer than other 
types of medicines. Majority of the patients did not 
combine Neopicrorhiza-containing Ayurvedic 
medicines with allopathic medicines. Neopicrorhiza-
containing Ayurvedic medicines are commonly used to 
treat health disorders related to Circulatory system, 
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Digestive system, Hepatobiliary system, Immune 
system, Integumentary system, Muscular system, 
Nervous system, Reproductive system, Respiratory 
system, Skeleton system and Urinary system. The first 
three health disorders for which more patients receive 
Ayurvedic medicines containing Neopicrorhiza for 
treatment were digestive system disorders, hepatobiliary 
system disorders, and respiratory system disorders. 
Looking at the multiple uses of Ayurvedic medicines 
containing Kutki and consumers of diverse socio-
economic background, it is speculated that the domestic 
demand of these medicines, therefore of dry rhizomes of 
Neopicrorhiza for manufacturing of those medicines, 
could rise in future. Similar consumption studies are 
recommended in India and China where the 
Neopicrorhiza from Nepal is exported, so that driving 
factors of demand for this species at regional level is 
identified. The consumption of the end products of 
Neopicrorhiza was driven by the preference of 
consumers towards Ayurvedic methods for treatment of 
health disorders. So further research is recommended to 
explore why the consumers choose to use Ayurvedic 
medicines for their healthcare. 
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